Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver

B Grasl-Kraupp, W Bursch, B Ruttkay-Nedecky, A Wagner, B Lauer, R Schulte-Hermann, B Grasl-Kraupp, W Bursch, B Ruttkay-Nedecky, A Wagner, B Lauer, R Schulte-Hermann

Abstract

Restriction of dietary calories reduces cancer formation in experimental animals and probably also in humans. This effect is generally attributed to the inhibitory effect of fasting on cell proliferation. Here we studied the effect of fasting on physiological cell death through apoptosis by using rat liver as a model. (i) In normal liver, involution of hyperplasia by apoptosis was reinforced by food withdrawal and suppressed by feeding. Complete food withdrawal for 8 days or food reduction by 40% for 3 months eliminated 20-30% of normal liver cells through apoptosis. (ii) Putative preneoplastic liver foci exhibited severalfold higher rates of DNA replication and apoptosis than unaltered liver. Food restriction lowered DNA replication but increased apoptosis, which reduced the number and volume of putative preneoplastic liver foci by 85% within 3 months. Subsequent return to ad libitum feeding normalized cell replication and apoptosis but clear differences in the volume and number of putative preneoplastic liver foci persisted throughout the following 17 months. Treatment of animals after food restriction with nafenopin, a peroxisome proliferator and potent tumor promoter, produced only half as many hepatocellular adenomas and carcinomas as in animals fed unrestrictedly throughout their lifetime. This indicates that food restriction had actually eliminated a part of the initiated cells. This study demonstrates that food restriction preferentially enhances apoptosis of preneoplastic cells. This effect in combination with lowered cell replication provides protection from carcinogenesis.

References

    1. Cancer. 1989 Aug 1;64(3):686-90
    1. N Engl J Med. 1990 Dec 13;323(24):1664-72
    1. J Natl Cancer Inst. 1990 Oct 17;82(20):1615-20
    1. Cancer Res. 1991 Jan 15;51(2):666-71
    1. Cancer Res. 1983 Feb;43(2):839-44
    1. Cancer Res. 1987 Apr 15;47(8):1987-92
    1. Science. 1971 May 14;172(3984):738-41
    1. Lab Invest. 1992 Oct;67(4):413-5
    1. Annu Rev Pharmacol Toxicol. 1990;30:465-500
    1. Science. 1987 Apr 17;236(4799):271-80
    1. Cancer Res. 1982 Dec;42(12):4943-7
    1. Virchows Arch A Pathol Anat Histol. 1981;393(2):193-203
    1. Carcinogenesis. 1993 Nov;14(11):2407-12
    1. Fed Proc. 1976 May 1;35(6):1316-21
    1. Cancer Res. 1990 Aug 15;50(16):5127-35
    1. Cancer Res. 1990 Jun 15;50(12):3748-53
    1. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5408-12
    1. Cancer Res. 1977 Jan;37(1):166-71
    1. Cancer Res. 1987 Jun 1;47(11):2759-62
    1. J Natl Cancer Inst. 1986 Feb;76(2):335-8
    1. Jpn J Cancer Res. 1986 Jul;77(7):629-38
    1. Virchows Arch B Cell Pathol Incl Mol Pathol. 1985;50(2):153-66
    1. Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9112-6
    1. Environ Health Perspect. 1983 Apr;50:185-94
    1. Cancer Res. 1992 Apr 1;52(7 Suppl):2030s-2034s
    1. Int J Cancer. 1993 Sep 30;55(3):498-505
    1. J Natl Cancer Inst. 1981 Dec;67(6):1327-32
    1. J Natl Cancer Inst. 1981 Jun;66(6):1191-308
    1. Cancer Lett. 1990 May 15;51(1):67-73
    1. Adv Cancer Res. 1953;1:451-501
    1. Cancer Causes Control. 1990 Jul;1(1):81-97; discussion 99-109
    1. Carcinogenesis. 1990 Aug;11(8):1271-8
    1. Cancer Res. 1990 Sep 15;50(18):5710-9
    1. Cancer Res. 1984 Aug;44(8):3174-7

Source: PubMed

3
Tilaa